Efficacy and safety of lomitapide in familial chylomicronaemia syndrome
Open Access
- 10 September 2022
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 359, 13-19
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Severe Hypertriglyceridemia With PancreatitisJAMA Internal Medicine, 2014
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyThe Lancet, 2013
- Effect of Alipogene Tiparvovec (AAV1-LPLS447X) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient PatientsThe Journal of Clinical Endocrinology & Metabolism, 2012
- Invited CommentaryRadioGraphics, 2009
- FIB-4Hepatology, 2007
- The NAFLD fibrosis scoreHepatology, 2007
- Inhibition of Microsomal Triglyceride Transfer Protein in Familial HypercholesterolemiaNew England Journal of Medicine, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemiaNature, 1993
- The role of the cholesteryl ester transfer protein in lipoprotein metabolismDiabetes/Metabolism Research and Reviews, 1991